PG
The Procter & Gamble Company
PG's fundamentals are mixed: it turned 17% of its revenue into free cash flow, but its operating margin fell 2 points to 23%. At 25x earnings, it's trading right at its usual valuation. Analysts expect earnings growth.
PG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
PG's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
PG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 23x | $156 | -7.2% |
| Forward | 24x | $168 | — |
| Current | 25x | $168 | — |
| Fair | 26x | $173 | +2.8% |
| Expensive | 28x | $189 | +12% |
Historical ranges are pointers, not guarantees.
PG's PE is in its fair range at 25x. If earnings grow as analysts expect, today's price would be 24x next year's earnings, in its cheap range.
PG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| High |
Analysts expect PG's earnings to grow and its profitability to improve, with its revenue holding steady.
PG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.08 | +6.7% |
| Q3 2026 | $6.64 | -3.1% |
| Q2 2026 | $6.62 | +1.7% |
| Q1 2026 | $6.84 | +8.6% |
| Q4 2025 | $6.75 | +7.5% |
| Q3 2025 | $6.85 | +18% |
| Q2 2025 | $6.51 | +8.1% |
| Q1 2025 | $6.30 | +2.9% |
| Q4 2024 | $6.28 | +5.2% |
PG earned $6.64 per share over the past year, down 3.1% from the year before.
PG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.3B | +4% |
| Q2 2026 | $21.2B | +1.5% |
| Q1 2026 | $21.2B | +7.4% |
| Q4 2025 | $22.2B | +1.5% |
| Q3 2025 | $22.4B | +3% |
| Q2 2025 | $20.9B | +1.7% |
| Q1 2025 | $19.8B | -2.1% |
| Q4 2024 | $21.9B | +2.1% |
PG's revenue grew through 2023 and has held roughly level since: $23.3B last quarter, up 4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | -0.6 points |
| Q2 2026 | 19% | -2.2 points |
| Q1 2026 | 22% | -1.5 points |
| Q4 2025 | 24% | -2.1 points |
| Q3 2025 | 26% | -0.5 points |
| Q2 2025 | 21% | +1.9 points |
| Q1 2025 | 23% | +1 points |
| Q4 2024 | 26% | +5.6 points |
PG's operating margin was 26% last quarter, down 0.6 points from the same quarter a year ago.
PG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.4B | +4.6% |
| Q2 2026 | $4.1B | +3% |
| Q1 2026 | $3B | +6.3% |
| Q4 2025 | $3.8B | -2.4% |
| Q3 2025 | $4.2B | +27% |
| Q2 2025 | $4B | -20% |
| Q1 2025 | $2.8B | -14% |
| Q4 2024 | $3.9B | -8.9% |
PG's free cash flow has been positive every quarter for seven years: $15.3B over the past year, up 2.7% from the year before.
PG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -15.3M shares |
| 1 year | -1.2% | -29.6M shares |
| 3 years | -2.7% | -68M shares |
| 5 years | -5.9% | -152M shares |
| Available history | -8.5% | -223M shares |
PG has 2.4B diluted shares, down 1.2% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.3B |
| Q2 2026 | $875M |
| Q1 2026 | $625M |
| Q4 2025 | $2.3B |
| Q3 2025 | $1.3B |
| Q2 2025 | $700M |
| Q1 2025 | $1.4B |
| Q4 2024 | $2.5B |
PG spent $5B buying back its own shares over the past year, down 13% from the year before.
PG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.0x | Healthy |
| Q2 2026 | 1.1x | Healthy |
| Q1 2026 | 1.1x | Healthy |
| Q4 2025 | 1.1x | Healthy |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 1.1x | Healthy |
PG's net debt is about a year of its operating earnings (EBITDA), about the same as a year ago.
PG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.9 | Overbought |
| Stochastic | 84.5 | Overbought |
PG's weekly RSI is 74 (overbought) and its Stochastic is 85 (overbought).
PG PE vs Consumer Defensive Sector
| Metric | PG | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 19x | 30% above |
| PE % | 39 | 18 | 21 pts above |
PG is trading at 25x earnings, a 30% premium to the Consumer Defensive sector's median of 19x.
PG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $157.2 | 6.9% above |
| 20 week MA | $150.8 | 11% above |
| 50 week MA | $149.2 | 13% above |
| 100 week MA | $154.7 | 8.6% above |
| 200 week MA | $155.9 | 7.8% above |
PG has climbed back above all five of its weekly moving averages, and it's now 7.8% above its 200-week average.
PG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $126.1 | $137.7 | +9.2% |
| 2021 | $137.7 | $160.1 | +16% |
| 2022 | $160.1 | $152.6 | -4.7% |
| 2023 | $152.6 | $146.5 | -4% |
| 2024 | $146.5 | $169.5 | +16% |
| 2025 | $169.5 | $144.7 | -15% |
| 2026 YTD | $144.7 | $168.0 | +16% |
PG has finished lower in three of the last six years. It's up 16% so far in 2026.